Over 8 Million Americans Report Psilocybin Use in Past Year, Study Finds
Study: Millions in the US report past-year psilocybin use
Image: University Of Illinois Urbana-champaign
A recent survey reveals that more than 8 million Americans, or 2.8% of the population, reported using psilocybin in the past year. The study highlights demographic trends and associated risks, emphasizing the need for public health awareness as interest in psilocybin grows amid changing regulations.
- 01The 2024 National Survey on Drug Use and Health included responses from 58,000 individuals aged 12 and older.
- 02Psilocybin users tend to be white, male, younger, and more affluent compared to nonusers.
- 03The study indicates a significant overlap between psilocybin use and other mind-altering substances, raising concerns about poly-substance use.
- 04Psilocybin remains a Schedule I controlled substance at the federal level despite growing interest in its therapeutic potential.
- 05The average cost of psychedelic-assisted therapy can reach up to $6,500, limiting access for lower-income individuals.
Advertisement
In-Article Ad
A study published in the American Journal of Preventive Medicine Focus indicates that over 8 million Americans, approximately 2.8% of the population, reported psilocybin use in the past year, according to the 2024 National Survey on Drug Use and Health. The survey, which included 58,000 respondents aged 12 and older, found that psilocybin users are predominantly white, male, younger, and more affluent than nonusers. Interest in psilocybin has surged due to its potential therapeutic uses for conditions such as depression and anxiety, particularly as regulatory restrictions have begun to ease. However, psilocybin remains classified as a Schedule I controlled substance federally. The study also highlights the risks associated with psilocybin use, especially when combined with other substances, and the lack of data on dosage and source potency due to self-reporting limitations. Researchers emphasize the need for public health awareness as psilocybin use becomes more common outside clinical settings, particularly among individuals with higher incomes who can afford therapy costs. The findings suggest that clinicians and policymakers should pay attention to this growing trend to develop effective harm reduction strategies.
Advertisement
In-Article Ad
The findings indicate a significant prevalence of psilocybin use, necessitating public health responses to address potential risks and inform users.
Advertisement
In-Article Ad
Reader Poll
What do you think about the growing use of psilocybin in the U.S.?
Connecting to poll...
Read the original article
Visit the source for the complete story.





